Avadel Pharmaceuticals Plc

JPMORGAN CHASE & CO AVDL

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/10/2024

Shares

53,221

Value ($000)

899

Weight

0.0%

2019 Q4 - 2024 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/10/2024	899	0.0%	53,221	3/31/2024
2023 Q4	2/12/2024	681	0.0%	48,203	12/31/2023
2023 Q3	11/14/2023	4,660	0.0%	452,472	9/30/2023
2023 Q2	8/11/2023	5,482	0.0%	332,624	6/30/2023
2023 Q1	5/18/2023	3,278	0.0%	357,860	3/31/2023
2022 Q4	2/13/2023	176	0.0%	24,463	12/31/2022
2022 Q3	11/14/2022	135	0.0%	26,852	9/30/2022
2022 Q2	8/11/2022	60	0.0%	24,859	6/30/2022
2022 Q1	5/11/2022	202	0.0%	29,620	3/31/2022
2021 Q4	2/11/2022	225	0.0%	27,862	12/31/2021
2021 Q3	11/12/2021	2,434	0.0%	248,464	9/30/2021
2021 Q2	8/12/2021	1,399	0.0%	207,859	6/30/2021
2021 Q1	5/12/2021	2,739	0.0%	303,041	3/31/2021
2020 Q4	2/19/2021	3,087	0.0%	462,057	12/31/2020
2020 Q3	11/12/2020	1,702	0.0%	331,044	9/30/2020
2020 Q2	8/11/2020	2,821	0.0%	349,222	6/30/2020
2020 Q1	5/12/2020	180	0.0%	22,700	3/31/2020
2019 Q4	2/11/2020	171	0.0%	22,700	12/31/2019